References
- Sullivan DJ, Westemeng TJ, Haynes KA, Bennett DE, Cole-man DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
- Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557–567.
- Sullivan, DJ, Coleman, DC. Candida dubliniensis: character-istics and identification. J Clin Microbiol 1998; 36: 329–334.
- Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodefriency virus-infected individuals. J Clin Microbiol 1997; 35: 960–964.
- Jabra-Rizk MA, Baqui AA, Kelley JI, Falkler WA Jr, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 1999; 37: 321–326.
- Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodefriency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant deriva-tives in vitro. Antimicrob Agents Chemother 1997; 41: 617–623.
- Chen Y-C, Eisner JD, Kattar MM, et al. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 2000; 38:2302–2310.
- National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne (PA): The Committee; 1997.
- Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with che-motherapy-induced neutropenia and bone marrow transplanta-tion. Emerg Infect Dis 1999; 5: 150–153.
- Brandt ME, Harrison LH, Pass M, et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000; 6: 46–49.
- Pfaller MA, Messer SA, Gee S, etal. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Gun Microbiol 1999; 37: 870–872.
- Quindos G, Carrillo-Munoz AJ, Arevalo MP, et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000; 46: 395–401.